List of Studies ( Metabolite:PE 17:0/17:0)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST000911 | AN001481 | Insights into the pathogenesis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) through metabolomic profiling of cerebrospinal fluid (part II) | Cerebrospinal fluid | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | University of California, Davis | Counts |
ST000912 | AN001482 | Insights into the pathogenesis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) through metabolomic profiling of cerebrospinal fluid | Cerebrospinal fluid | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | University of California, Davis | Counts |
ST000983 | AN001609 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (Part I) | Blood | Human | University of California, Davis | nanograms (absolute) | |
ST000984 | AN001610 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part II) | Blood | Human | University of California, Davis | nanograms (absolute) | |
ST000985 | AN001611 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part III) | Blood | Human | University of California, Davis | nanograms (absolute) | |
ST000986 | AN001612 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IV) | Blood | Human | University of California, Davis | nanograms (absolute) | |
ST000987 | AN001613 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part V) | Blood | Human | University of California, Davis | nanograms (absolute) | |
ST000988 | AN001614 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VI) | Blood | Human | University of California, Davis | nanograms (absolute) | |
ST000989 | AN001615 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VII) | Blood | Human | University of California, Davis | nanograms (absolute) | |
ST000990 | AN001616 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VIII) | Blood | Human | University of California, Davis | nanograms (absolute) | |
ST000991 | AN001617 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IX) | Blood | Human | University of California, Davis | nanograms (absolute) | |
ST003162 | AN005189 | Loss of dihydroceramide desaturase drives neurodegeneration by disrupting endoplasmic reticulum and lipid droplet homeostasis in glial cells | CNS | Drosophila melanogaster | Brain disease | Washington University in St. Louis | peak area |
ST003162 | AN005189 | Loss of dihydroceramide desaturase drives neurodegeneration by disrupting endoplasmic reticulum and lipid droplet homeostasis in glial cells | Larvae | Drosophila melanogaster | Brain disease | Washington University in St. Louis | peak area |
ST003162 | AN005190 | Loss of dihydroceramide desaturase drives neurodegeneration by disrupting endoplasmic reticulum and lipid droplet homeostasis in glial cells | CNS | Drosophila melanogaster | Brain disease | Washington University in St. Louis | peak area |
ST003162 | AN005190 | Loss of dihydroceramide desaturase drives neurodegeneration by disrupting endoplasmic reticulum and lipid droplet homeostasis in glial cells | Larvae | Drosophila melanogaster | Brain disease | Washington University in St. Louis | peak area |
ST000246 | AN000384 | Lipid Extraction Efficiency Comparison | Cells | Human | University of Florida | Peak area | |
ST000344 | AN000557 | Effects of dietary supplement on hamster metabolism | Cultured cells | Hamster | University of California, Davis | Peak height | |
ST000344 | AN000558 | Effects of dietary supplement on hamster metabolism | Cultured cells | Hamster | University of California, Davis | Peak height | |
ST000346 | AN000561 | Metabolites detected from human bronchoalveolar lavage | Lung | Human | University of California, Davis | Peak height | |
ST000354 | AN000577 | Metabolite comparison of mouse gastric tissue and glands | Stomach | Mouse | University of California, Davis | Peak height | |
ST001102 | AN001791 | Physiological and metabolic response of crab megalopae and juveniles to ocean acidification (part-II) | Whole animals | Crab | NOAA NWFSC, | Peak height | |
ST001165 | AN001926 | Physiological and metabolic response of crab megalopae and juveniles to ocean acidification (part-III) | Whole animals | Crab | NOAA NWFSC | Peak height | |
ST001165 | AN001927 | Physiological and metabolic response of crab megalopae and juveniles to ocean acidification (part-III) | Whole animals | Crab | NOAA NWFSC | Peak height | |
ST001061 | AN001731 | Lipidomics of Near-Term Fetal and Newborn Sheep Cardiac Tissue | Heart | Sheep | University of Florida | Relative peak area | |
ST001061 | AN001732 | Lipidomics of Near-Term Fetal and Newborn Sheep Cardiac Tissue | Heart | Sheep | University of Florida | Relative peak area | |
ST001106 | AN001799 | Lipidomics of Newborn Heart Tissue Exposed to Excess Maternal Cortisol in Late Gestation (part-1) | Heart | Sheep | University of Florida | Relative peak area | |
ST001106 | AN001800 | Lipidomics of Newborn Heart Tissue Exposed to Excess Maternal Cortisol in Late Gestation (part-1) | Heart | Sheep | University of Florida | Relative peak area |